A recent study showed that ionomycin is a negative regulator of β-catenin/TCF signaling in colon cancer cells and its inhibitory mechanism is related to the decreased nuclear β-catenin products and to the suppressed binding of TCF complexes to consensus DNA [8]. This evidence concerns the gene HNF4A and colonic neoplasm.